<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/" xmlns:ynews="http://news.yahoo.com/rss/">
    <channel>
        <title>Nova Reader - Subject</title>
        <link>https://www.novareader.co</link>
        <description>Default RSS Feed</description>
        <language>en-us</language>
        <copyright>Newgen KnowledgeWorks</copyright>
        <item>
            <title><![CDATA[Loss of CBX2 induces genome instability and senescence-associated chromosomal rearrangements]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766056428900-b4d43353-8deb-4785-9b1a-b016e5aaccac/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1083/jcb.201910149</link>
            <description><![CDATA[<p class="para" id="N65540">Polycomb group proteins play important roles in developmental and cell proliferation processes. Baumann et al. demonstrate that the PRC1 protein CBX2 is critical for heterochromatin homeostasis, chromosome stability, and the prevention of premature cellular senescence.</p><p class="para" id="N65539">The polycomb group protein CBX2 is an important epigenetic reader involved in cell proliferation and differentiation. While CBX2 overexpression occurs in a wide range of human tumors, targeted deletion results in homeotic transformation, proliferative defects, and premature senescence. However, its cellular function(s) and whether it plays a role in maintenance of genome stability remain to be determined. Here, we demonstrate that loss of CBX2 in mouse fibroblasts induces abnormal large-scale chromatin structure and chromosome instability. Integrative transcriptome analysis and ATAC-seq revealed a significant dysregulation of transcripts involved in DNA repair, chromocenter formation, and tumorigenesis in addition to changes in chromatin accessibility of genes involved in lateral sclerosis, basal transcription factors, and folate metabolism. Notably, Cbx2<sup>−/−</sup> cells exhibit prominent decondensation of satellite DNA sequences at metaphase and increased sister chromatid recombination events leading to rampant chromosome instability. The presence of extensive centromere and telomere defects suggests a prominent role for CBX2 in heterochromatin homeostasis and the regulation of nuclear architecture.</p>]]></description>
            <pubDate><![CDATA[2020-09-01T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Pluripotent stem cells with low differentiation potential contain incompletely reprogrammed DNA replication]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765973935156-ef8ea411-1b28-45f3-a441-f5d419b11b8d/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1083/jcb.201909163</link>
            <description><![CDATA[<p class="para" id="N65540">Differentiation potential varies among reprogrammed pluripotent stem cells (PSCs), but the factors contributing to this variability are not understood. Paniza et al. show that reprogramming of DNA replication is incomplete and genomic instability is increased in PSCs with low differentiation potential.</p><p class="para" id="N65539">Reprogrammed pluripotent stem cells (PSCs) are valuable for research and potentially for cell replacement therapy. However, only a fraction of reprogrammed PSCs are developmentally competent. Genomic stability and accurate DNA synthesis are fundamental for cell development and critical for safety. We analyzed whether defects in DNA replication contribute to genomic instability and the diverse differentiation potentials of reprogrammed PSCs. Using a unique single-molecule approach, we visualized DNA replication in isogenic PSCs generated by different reprogramming approaches, either somatic cell nuclear transfer (NT-hESCs) or with defined factors (iPSCs). In PSCs with lower differentiation potential, DNA replication was incompletely reprogrammed, and genomic instability increased during replicative stress. Reprogramming of DNA replication did not correlate with DNA methylation. Instead, fewer replication origins and a higher frequency of DNA breaks in PSCs with incompletely reprogrammed DNA replication were found. Given the impact of error-free DNA synthesis on the genomic integrity and differentiation proficiency of PSCs, analyzing DNA replication may be a useful quality control tool.</p>]]></description>
            <pubDate><![CDATA[2020-07-16T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Interferon-stimulated gene 15 accelerates replication fork progression inducing chromosomal breakage]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765840075720-e8b8e0ea-0fc0-48b8-907b-7c50a989b9e5/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1083/jcb.202002175</link>
            <description><![CDATA[<p class="para" id="N65540">Raso et al. find that high levels of interferon-stimulated gene 15 (ISG15), which is very frequent in cancer and robustly induced by pathogen infection, accelerate DNA replication fork progression, impacting genome stability and response to chemotherapy.</p><p class="para" id="N65539">DNA replication is highly regulated by the ubiquitin system, which plays key roles upon stress. The ubiquitin-like modifier ISG15 (interferon-stimulated gene 15) is induced by interferons, bacterial and viral infection, and DNA damage, but it is also constitutively expressed in many types of cancer, although its role in tumorigenesis is still largely elusive. Here, we show that ISG15 localizes at the replication forks, in complex with PCNA and the nascent DNA, where it regulates DNA synthesis. Indeed, high levels of ISG15, intrinsic or induced by interferon-β, accelerate DNA replication fork progression, resulting in extensive DNA damage and chromosomal aberrations. This effect is largely independent of ISG15 conjugation and relies on ISG15 functional interaction with the DNA helicase RECQ1, which promotes restart of stalled replication forks. Additionally, elevated ISG15 levels sensitize cells to cancer chemotherapeutic treatments. We propose that ISG15 up-regulation exposes cells to replication stress, impacting genome stability and response to genotoxic drugs.</p>]]></description>
            <pubDate><![CDATA[2020-06-29T00:00]]></pubDate>
        </item>
    </channel>
</rss>